Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 November 2022 | Story Gerda-Marié van Rooyen
Antjie Krog at UFS
The award-winning writer, Antjie Krog, will be the keynote speaker at the International Hybrid Conference from 24 to 26 November 2022. This conference is a joint venture of the University of the Free State (UFS) Centre for Gender and Africa Studies and the War Museum.

The award-winning writer, Antjie Krog, will be the keynote speaker later this week at an International Hybrid Conference titled, The Unsung Heroines and Youth of South Africa: Violent Histories and Experiences of South African Women and Children during Wars, Conflicts and Pandemics. This conference – a joint project of the Centre for Gender and Africa Studies at the University of the Free State (UFS) and the War Museum – starts on Thursday 24 November and will be hosted at the War Museum in Bloemfontein and broadcast online. The three-day conference overlaps with the global 16 Days of Activism Against Gender-Based Violence and aims to assemble historians, academics, and other scholars researching the violent histories of not only women and children in the South African War but in other wars, conflicts, and pandemics as well.

Prof Krog, an Extraordinary Professor in the Faculty of Arts at the University of the Western Cape, poet, and author of Country of my Skull (among other books), is an alumna of the UFS, where she completed a BA degree with Afrikaans, Philosophy, and English. She will deliver her keynote address, Survival, Complicity, and Race: (Im)possibilities of Narrating and Interpreting Rape in Havenga Affidavits, on the first day of the conference.

Prof Heidi Hudson, Dean of the Faculty of the Humanities at the UFS, will deliver her keynote address on Friday (25 November 2022). Prof Hudson is considered a specialist in feminist security studies. Her keynote address is titled Disciplinary and other stories: From women’s peace movements to the Women, Peace and Security ecosystem.

Several historians, academics, and scholars will either present their research or attend the conference. The conference aims to gather various stakeholders who are researching the violent histories of not only the women and children in the South African War, but other wars, conflicts, and pandemics in South African history dating from precolonial times to the World Wars, Apartheid, to the present. Each of the eight sessions over the first two days will conclude with time set aside for discussion.

The conference programme includes a visit to the art exhibition Unsung Heroes at the Oliewenhuis Art Museum on Friday after the last session. On Saturday, conference attendees can look forward to a tour of Bloemfontein. Click here for more information or send an email to vicky@anglo-boer.co.za.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept